Global RNA Vaccines Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
Based on the RNA Vaccines market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global RNA Vaccines market covered in Chapter 5:
Argos Therapeutics
eTheRNA
BioNTech
Tiba Biotechnology
Moderna Therapeutics
Ethris
Sangamo Therapeutics
In-Cell-Art
CureVac
Translate Bio
In Chapter 6, on the basis of types, the RNA Vaccines market from 2015 to 2025 is primarily split into:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
In Chapter 7, on the basis of applications, the RNA Vaccines market from 2015 to 2025 covers:
Infectious Disease
Cancer
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the RNA Vaccines market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global RNA Vaccines market covered in Chapter 5:
Argos Therapeutics
eTheRNA
BioNTech
Tiba Biotechnology
Moderna Therapeutics
Ethris
Sangamo Therapeutics
In-Cell-Art
CureVac
Translate Bio
In Chapter 6, on the basis of types, the RNA Vaccines market from 2015 to 2025 is primarily split into:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
In Chapter 7, on the basis of applications, the RNA Vaccines market from 2015 to 2025 covers:
Infectious Disease
Cancer
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global RNA Vaccines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Argos Therapeutics
5.1.1 Argos Therapeutics Company Profile
5.1.2 Argos Therapeutics Business Overview
5.1.3 Argos Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Argos Therapeutics RNA Vaccines Products Introduction
5.2 eTheRNA
5.2.1 eTheRNA Company Profile
5.2.2 eTheRNA Business Overview
5.2.3 eTheRNA RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 eTheRNA RNA Vaccines Products Introduction
5.3 BioNTech
5.3.1 BioNTech Company Profile
5.3.2 BioNTech Business Overview
5.3.3 BioNTech RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioNTech RNA Vaccines Products Introduction
5.4 Tiba Biotechnology
5.4.1 Tiba Biotechnology Company Profile
5.4.2 Tiba Biotechnology Business Overview
5.4.3 Tiba Biotechnology RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Tiba Biotechnology RNA Vaccines Products Introduction
5.5 Moderna Therapeutics
5.5.1 Moderna Therapeutics Company Profile
5.5.2 Moderna Therapeutics Business Overview
5.5.3 Moderna Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Moderna Therapeutics RNA Vaccines Products Introduction
5.6 Ethris
5.6.1 Ethris Company Profile
5.6.2 Ethris Business Overview
5.6.3 Ethris RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Ethris RNA Vaccines Products Introduction
5.7 Sangamo Therapeutics
5.7.1 Sangamo Therapeutics Company Profile
5.7.2 Sangamo Therapeutics Business Overview
5.7.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sangamo Therapeutics RNA Vaccines Products Introduction
5.8 In-Cell-Art
5.8.1 In-Cell-Art Company Profile
5.8.2 In-Cell-Art Business Overview
5.8.3 In-Cell-Art RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 In-Cell-Art RNA Vaccines Products Introduction
5.9 CureVac
5.9.1 CureVac Company Profile
5.9.2 CureVac Business Overview
5.9.3 CureVac RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 CureVac RNA Vaccines Products Introduction
5.10 Translate Bio
5.10.1 Translate Bio Company Profile
5.10.2 Translate Bio Business Overview
5.10.3 Translate Bio RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Translate Bio RNA Vaccines Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global RNA Vaccines Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global RNA Vaccines Sales and Market Share by Types (2015-2020)
6.1.2 Global RNA Vaccines Revenue and Market Share by Types (2015-2020)
6.1.3 Global RNA Vaccines Price by Types (2015-2020)
6.2 Global RNA Vaccines Market Forecast by Types (2020-2025)
6.2.1 Global RNA Vaccines Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global RNA Vaccines Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global RNA Vaccines Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global RNA Vaccines Sales, Price and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
6.3.2 Global RNA Vaccines Sales, Price and Growth Rate of Infectious Disease Treatment MRNA Vaccine
6.3.3 Global RNA Vaccines Sales, Price and Growth Rate of Infection Prevention MRNA Vaccine
6.4 Global RNA Vaccines Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Individualized Cancer Treatment MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
6.4.2 Infectious Disease Treatment MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
6.4.3 Infection Prevention MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global RNA Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global RNA Vaccines Sales and Market Share by Applications (2015-2020)
7.1.2 Global RNA Vaccines Revenue and Market Share by Applications (2015-2020)
7.2 Global RNA Vaccines Market Forecast by Applications (2020-2025)
7.2.1 Global RNA Vaccines Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global RNA Vaccines Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global RNA Vaccines Revenue, Sales and Growth Rate of Infectious Disease (2015-2020)
7.3.2 Global RNA Vaccines Revenue, Sales and Growth Rate of Cancer (2015-2020)
7.3.3 Global RNA Vaccines Revenue, Sales and Growth Rate of Other (2015-2020)
7.4 Global RNA Vaccines Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Infectious Disease Market Revenue and Sales Forecast (2020-2025)
7.4.2 Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Other Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global RNA Vaccines Sales by Regions (2015-2020)
8.2 Global RNA Vaccines Market Revenue by Regions (2015-2020)
8.3 Global RNA Vaccines Market Forecast by Regions (2020-2025)
9 NORTH AMERICA RNA VACCINES MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America RNA Vaccines Market Sales and Growth Rate (2015-2020)
9.3 North America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
9.4 North America RNA Vaccines Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America RNA Vaccines Market Analysis by Country
9.6.1 U.S. RNA Vaccines Sales and Growth Rate
9.6.2 Canada RNA Vaccines Sales and Growth Rate
9.6.3 Mexico RNA Vaccines Sales and Growth Rate
10 EUROPE RNA VACCINES MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe RNA Vaccines Market Sales and Growth Rate (2015-2020)
10.3 Europe RNA Vaccines Market Revenue and Growth Rate (2015-2020)
10.4 Europe RNA Vaccines Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe RNA Vaccines Market Analysis by Country
10.6.1 Germany RNA Vaccines Sales and Growth Rate
10.6.2 United Kingdom RNA Vaccines Sales and Growth Rate
10.6.3 France RNA Vaccines Sales and Growth Rate
10.6.4 Italy RNA Vaccines Sales and Growth Rate
10.6.5 Spain RNA Vaccines Sales and Growth Rate
10.6.6 Russia RNA Vaccines Sales and Growth Rate
11 ASIA-PACIFIC RNA VACCINES MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific RNA Vaccines Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific RNA Vaccines Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific RNA Vaccines Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific RNA Vaccines Market Analysis by Country
11.6.1 China RNA Vaccines Sales and Growth Rate
11.6.2 Japan RNA Vaccines Sales and Growth Rate
11.6.3 South Korea RNA Vaccines Sales and Growth Rate
11.6.4 Australia RNA Vaccines Sales and Growth Rate
11.6.5 India RNA Vaccines Sales and Growth Rate
12 SOUTH AMERICA RNA VACCINES MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America RNA Vaccines Market Sales and Growth Rate (2015-2020)
12.3 South America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
12.4 South America RNA Vaccines Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America RNA Vaccines Market Analysis by Country
12.6.1 Brazil RNA Vaccines Sales and Growth Rate
12.6.2 Argentina RNA Vaccines Sales and Growth Rate
12.6.3 Columbia RNA Vaccines Sales and Growth Rate
13 MIDDLE EAST AND AFRICA RNA VACCINES MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa RNA Vaccines Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa RNA Vaccines Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa RNA Vaccines Market Analysis by Country
13.6.1 UAE RNA Vaccines Sales and Growth Rate
13.6.2 Egypt RNA Vaccines Sales and Growth Rate
13.6.3 South Africa RNA Vaccines Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global RNA Vaccines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Argos Therapeutics
5.1.1 Argos Therapeutics Company Profile
5.1.2 Argos Therapeutics Business Overview
5.1.3 Argos Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Argos Therapeutics RNA Vaccines Products Introduction
5.2 eTheRNA
5.2.1 eTheRNA Company Profile
5.2.2 eTheRNA Business Overview
5.2.3 eTheRNA RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 eTheRNA RNA Vaccines Products Introduction
5.3 BioNTech
5.3.1 BioNTech Company Profile
5.3.2 BioNTech Business Overview
5.3.3 BioNTech RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioNTech RNA Vaccines Products Introduction
5.4 Tiba Biotechnology
5.4.1 Tiba Biotechnology Company Profile
5.4.2 Tiba Biotechnology Business Overview
5.4.3 Tiba Biotechnology RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Tiba Biotechnology RNA Vaccines Products Introduction
5.5 Moderna Therapeutics
5.5.1 Moderna Therapeutics Company Profile
5.5.2 Moderna Therapeutics Business Overview
5.5.3 Moderna Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Moderna Therapeutics RNA Vaccines Products Introduction
5.6 Ethris
5.6.1 Ethris Company Profile
5.6.2 Ethris Business Overview
5.6.3 Ethris RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Ethris RNA Vaccines Products Introduction
5.7 Sangamo Therapeutics
5.7.1 Sangamo Therapeutics Company Profile
5.7.2 Sangamo Therapeutics Business Overview
5.7.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sangamo Therapeutics RNA Vaccines Products Introduction
5.8 In-Cell-Art
5.8.1 In-Cell-Art Company Profile
5.8.2 In-Cell-Art Business Overview
5.8.3 In-Cell-Art RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 In-Cell-Art RNA Vaccines Products Introduction
5.9 CureVac
5.9.1 CureVac Company Profile
5.9.2 CureVac Business Overview
5.9.3 CureVac RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 CureVac RNA Vaccines Products Introduction
5.10 Translate Bio
5.10.1 Translate Bio Company Profile
5.10.2 Translate Bio Business Overview
5.10.3 Translate Bio RNA Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Translate Bio RNA Vaccines Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global RNA Vaccines Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global RNA Vaccines Sales and Market Share by Types (2015-2020)
6.1.2 Global RNA Vaccines Revenue and Market Share by Types (2015-2020)
6.1.3 Global RNA Vaccines Price by Types (2015-2020)
6.2 Global RNA Vaccines Market Forecast by Types (2020-2025)
6.2.1 Global RNA Vaccines Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global RNA Vaccines Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global RNA Vaccines Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global RNA Vaccines Sales, Price and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
6.3.2 Global RNA Vaccines Sales, Price and Growth Rate of Infectious Disease Treatment MRNA Vaccine
6.3.3 Global RNA Vaccines Sales, Price and Growth Rate of Infection Prevention MRNA Vaccine
6.4 Global RNA Vaccines Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Individualized Cancer Treatment MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
6.4.2 Infectious Disease Treatment MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
6.4.3 Infection Prevention MRNA Vaccine Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global RNA Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global RNA Vaccines Sales and Market Share by Applications (2015-2020)
7.1.2 Global RNA Vaccines Revenue and Market Share by Applications (2015-2020)
7.2 Global RNA Vaccines Market Forecast by Applications (2020-2025)
7.2.1 Global RNA Vaccines Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global RNA Vaccines Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global RNA Vaccines Revenue, Sales and Growth Rate of Infectious Disease (2015-2020)
7.3.2 Global RNA Vaccines Revenue, Sales and Growth Rate of Cancer (2015-2020)
7.3.3 Global RNA Vaccines Revenue, Sales and Growth Rate of Other (2015-2020)
7.4 Global RNA Vaccines Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Infectious Disease Market Revenue and Sales Forecast (2020-2025)
7.4.2 Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Other Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global RNA Vaccines Sales by Regions (2015-2020)
8.2 Global RNA Vaccines Market Revenue by Regions (2015-2020)
8.3 Global RNA Vaccines Market Forecast by Regions (2020-2025)
9 NORTH AMERICA RNA VACCINES MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America RNA Vaccines Market Sales and Growth Rate (2015-2020)
9.3 North America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
9.4 North America RNA Vaccines Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America RNA Vaccines Market Analysis by Country
9.6.1 U.S. RNA Vaccines Sales and Growth Rate
9.6.2 Canada RNA Vaccines Sales and Growth Rate
9.6.3 Mexico RNA Vaccines Sales and Growth Rate
10 EUROPE RNA VACCINES MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe RNA Vaccines Market Sales and Growth Rate (2015-2020)
10.3 Europe RNA Vaccines Market Revenue and Growth Rate (2015-2020)
10.4 Europe RNA Vaccines Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe RNA Vaccines Market Analysis by Country
10.6.1 Germany RNA Vaccines Sales and Growth Rate
10.6.2 United Kingdom RNA Vaccines Sales and Growth Rate
10.6.3 France RNA Vaccines Sales and Growth Rate
10.6.4 Italy RNA Vaccines Sales and Growth Rate
10.6.5 Spain RNA Vaccines Sales and Growth Rate
10.6.6 Russia RNA Vaccines Sales and Growth Rate
11 ASIA-PACIFIC RNA VACCINES MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific RNA Vaccines Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific RNA Vaccines Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific RNA Vaccines Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific RNA Vaccines Market Analysis by Country
11.6.1 China RNA Vaccines Sales and Growth Rate
11.6.2 Japan RNA Vaccines Sales and Growth Rate
11.6.3 South Korea RNA Vaccines Sales and Growth Rate
11.6.4 Australia RNA Vaccines Sales and Growth Rate
11.6.5 India RNA Vaccines Sales and Growth Rate
12 SOUTH AMERICA RNA VACCINES MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America RNA Vaccines Market Sales and Growth Rate (2015-2020)
12.3 South America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
12.4 South America RNA Vaccines Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America RNA Vaccines Market Analysis by Country
12.6.1 Brazil RNA Vaccines Sales and Growth Rate
12.6.2 Argentina RNA Vaccines Sales and Growth Rate
12.6.3 Columbia RNA Vaccines Sales and Growth Rate
13 MIDDLE EAST AND AFRICA RNA VACCINES MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa RNA Vaccines Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa RNA Vaccines Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa RNA Vaccines Market Analysis by Country
13.6.1 UAE RNA Vaccines Sales and Growth Rate
13.6.2 Egypt RNA Vaccines Sales and Growth Rate
13.6.3 South Africa RNA Vaccines Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global RNA Vaccines Market Size and Growth Rate 2015-2025
Table RNA Vaccines Key Market Segments
Figure Global RNA Vaccines Market Revenue ($) Segment by Type from 2015-2020
Figure Global RNA Vaccines Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of RNA Vaccines
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Argos Therapeutics Company Profile
Table Argos Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Argos Therapeutics Production and Growth Rate
Figure Argos Therapeutics Market Revenue ($) Market Share 2015-2020
Table eTheRNA Company Profile
Table eTheRNA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure eTheRNA Production and Growth Rate
Figure eTheRNA Market Revenue ($) Market Share 2015-2020
Table BioNTech Company Profile
Table BioNTech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioNTech Production and Growth Rate
Figure BioNTech Market Revenue ($) Market Share 2015-2020
Table Tiba Biotechnology Company Profile
Table Tiba Biotechnology Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tiba Biotechnology Production and Growth Rate
Figure Tiba Biotechnology Market Revenue ($) Market Share 2015-2020
Table Moderna Therapeutics Company Profile
Table Moderna Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Moderna Therapeutics Production and Growth Rate
Figure Moderna Therapeutics Market Revenue ($) Market Share 2015-2020
Table Ethris Company Profile
Table Ethris Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ethris Production and Growth Rate
Figure Ethris Market Revenue ($) Market Share 2015-2020
Table Sangamo Therapeutics Company Profile
Table Sangamo Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sangamo Therapeutics Production and Growth Rate
Figure Sangamo Therapeutics Market Revenue ($) Market Share 2015-2020
Table In-Cell-Art Company Profile
Table In-Cell-Art Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure In-Cell-Art Production and Growth Rate
Figure In-Cell-Art Market Revenue ($) Market Share 2015-2020
Table CureVac Company Profile
Table CureVac Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CureVac Production and Growth Rate
Figure CureVac Market Revenue ($) Market Share 2015-2020
Table Translate Bio Company Profile
Table Translate Bio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Translate Bio Production and Growth Rate
Figure Translate Bio Market Revenue ($) Market Share 2015-2020
Table Global RNA Vaccines Sales by Types (2015-2020)
Table Global RNA Vaccines Sales Share by Types (2015-2020)
Table Global RNA Vaccines Revenue ($) by Types (2015-2020)
Table Global RNA Vaccines Revenue Share by Types (2015-2020)
Table Global RNA Vaccines Price ($) by Types (2015-2020)
Table Global RNA Vaccines Market Forecast Sales by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Types (2020-2025)
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2015-2020)
Figure Global Infectious Disease Treatment MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Infectious Disease Treatment MRNA Vaccine Price (2015-2020)
Figure Global Infection Prevention MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Infection Prevention MRNA Vaccine Price (2015-2020)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)
Table Global RNA Vaccines Sales by Applications (2015-2020)
Table Global RNA Vaccines Sales Share by Applications (2015-2020)
Table Global RNA Vaccines Revenue ($) by Applications (2015-2020)
Table Global RNA Vaccines Revenue Share by Applications (2015-2020)
Table Global RNA Vaccines Market Forecast Sales by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Infectious Disease Sales and Growth Rate (2015-2020)
Figure Global Infectious Disease Price (2015-2020)
Figure Global Cancer Sales and Growth Rate (2015-2020)
Figure Global Cancer Price (2015-2020)
Figure Global Other Sales and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Cancer (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Cancer (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Other (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate (2015-2020)
Table Global RNA Vaccines Sales by Regions (2015-2020)
Table Global RNA Vaccines Sales Market Share by Regions (2015-2020)
Figure Global RNA Vaccines Sales Market Share by Regions in 2019
Figure Global RNA Vaccines Revenue and Growth Rate (2015-2020)
Table Global RNA Vaccines Revenue by Regions (2015-2020)
Table Global RNA Vaccines Revenue Market Share by Regions (2015-2020)
Figure Global RNA Vaccines Revenue Market Share by Regions in 2019
Table Global RNA Vaccines Market Forecast Sales by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Regions (2020-2025)
Figure North America RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure North America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure North America RNA Vaccines Market Forecast Sales (2020-2025)
Figure North America RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Canada RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Mexico RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Forecast Sales (2020-2025)
Figure Europe RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure United Kingdom RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure France RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Italy RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Spain RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Russia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Forecast Sales (2020-2025)
Figure Asia-Pacific RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Japan RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Korea RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Australia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure India RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Forecast Sales (2020-2025)
Figure South America RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Brazil RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Argentina RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Columbia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Forecast Sales (2020-2025)
Figure Middle East and Africa RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure UAE RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Egypt RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global RNA Vaccines Market Size and Growth Rate 2015-2025
Table RNA Vaccines Key Market Segments
Figure Global RNA Vaccines Market Revenue ($) Segment by Type from 2015-2020
Figure Global RNA Vaccines Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of RNA Vaccines
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Argos Therapeutics Company Profile
Table Argos Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Argos Therapeutics Production and Growth Rate
Figure Argos Therapeutics Market Revenue ($) Market Share 2015-2020
Table eTheRNA Company Profile
Table eTheRNA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure eTheRNA Production and Growth Rate
Figure eTheRNA Market Revenue ($) Market Share 2015-2020
Table BioNTech Company Profile
Table BioNTech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioNTech Production and Growth Rate
Figure BioNTech Market Revenue ($) Market Share 2015-2020
Table Tiba Biotechnology Company Profile
Table Tiba Biotechnology Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tiba Biotechnology Production and Growth Rate
Figure Tiba Biotechnology Market Revenue ($) Market Share 2015-2020
Table Moderna Therapeutics Company Profile
Table Moderna Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Moderna Therapeutics Production and Growth Rate
Figure Moderna Therapeutics Market Revenue ($) Market Share 2015-2020
Table Ethris Company Profile
Table Ethris Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ethris Production and Growth Rate
Figure Ethris Market Revenue ($) Market Share 2015-2020
Table Sangamo Therapeutics Company Profile
Table Sangamo Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sangamo Therapeutics Production and Growth Rate
Figure Sangamo Therapeutics Market Revenue ($) Market Share 2015-2020
Table In-Cell-Art Company Profile
Table In-Cell-Art Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure In-Cell-Art Production and Growth Rate
Figure In-Cell-Art Market Revenue ($) Market Share 2015-2020
Table CureVac Company Profile
Table CureVac Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CureVac Production and Growth Rate
Figure CureVac Market Revenue ($) Market Share 2015-2020
Table Translate Bio Company Profile
Table Translate Bio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Translate Bio Production and Growth Rate
Figure Translate Bio Market Revenue ($) Market Share 2015-2020
Table Global RNA Vaccines Sales by Types (2015-2020)
Table Global RNA Vaccines Sales Share by Types (2015-2020)
Table Global RNA Vaccines Revenue ($) by Types (2015-2020)
Table Global RNA Vaccines Revenue Share by Types (2015-2020)
Table Global RNA Vaccines Price ($) by Types (2015-2020)
Table Global RNA Vaccines Market Forecast Sales by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Types (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Types (2020-2025)
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2015-2020)
Figure Global Infectious Disease Treatment MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Infectious Disease Treatment MRNA Vaccine Price (2015-2020)
Figure Global Infection Prevention MRNA Vaccine Sales and Growth Rate (2015-2020)
Figure Global Infection Prevention MRNA Vaccine Price (2015-2020)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)
Table Global RNA Vaccines Sales by Applications (2015-2020)
Table Global RNA Vaccines Sales Share by Applications (2015-2020)
Table Global RNA Vaccines Revenue ($) by Applications (2015-2020)
Table Global RNA Vaccines Revenue Share by Applications (2015-2020)
Table Global RNA Vaccines Market Forecast Sales by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Applications (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Infectious Disease Sales and Growth Rate (2015-2020)
Figure Global Infectious Disease Price (2015-2020)
Figure Global Cancer Sales and Growth Rate (2015-2020)
Figure Global Cancer Price (2015-2020)
Figure Global Other Sales and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Infectious Disease (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Cancer (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Cancer (2020-2025)
Figure Global RNA Vaccines Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate Forecast of Other (2020-2025)
Figure Global RNA Vaccines Sales and Growth Rate (2015-2020)
Table Global RNA Vaccines Sales by Regions (2015-2020)
Table Global RNA Vaccines Sales Market Share by Regions (2015-2020)
Figure Global RNA Vaccines Sales Market Share by Regions in 2019
Figure Global RNA Vaccines Revenue and Growth Rate (2015-2020)
Table Global RNA Vaccines Revenue by Regions (2015-2020)
Table Global RNA Vaccines Revenue Market Share by Regions (2015-2020)
Figure Global RNA Vaccines Revenue Market Share by Regions in 2019
Table Global RNA Vaccines Market Forecast Sales by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Sales Share by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue ($) by Regions (2020-2025)
Table Global RNA Vaccines Market Forecast Revenue Share by Regions (2020-2025)
Figure North America RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure North America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure North America RNA Vaccines Market Forecast Sales (2020-2025)
Figure North America RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Canada RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Mexico RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Europe RNA Vaccines Market Forecast Sales (2020-2025)
Figure Europe RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure United Kingdom RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure France RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Italy RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Spain RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Russia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific RNA Vaccines Market Forecast Sales (2020-2025)
Figure Asia-Pacific RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Japan RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Korea RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Australia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure India RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure South America RNA Vaccines Market Forecast Sales (2020-2025)
Figure South America RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Brazil RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Argentina RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Columbia RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa RNA Vaccines Market Forecast Sales (2020-2025)
Figure Middle East and Africa RNA Vaccines Market Forecast Revenue ($) (2020-2025)
Figure UAE RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure Egypt RNA Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Africa RNA Vaccines Market Sales and Growth Rate (2015-2020)
